Skip to main content

Table 2 Reports on M. phlei infections

From: Pathogenicity of Mycolicibacterium phlei, a non-pathogenic nontuberculous mycobacterium in an immunocompetent host carrying anti-interferon gamma autoantibodies: a case report

No. [Reference] Age /Gender Infected Organs Background Immuno- suppressive drug Medication Duration of therapy/ clinical outcome
1. [2] 7/M synovial fluid and tissue healthy none INH, RFP, and SM 9 month/cured
2. [3] 49/M flexor digitorum longus and posterior tibialis tendon of his right foot. healthy none CAM and CPFX 2 month/cured
3. [4] 17/M peritonitis CAPD due to FSGS none AMK, CFX and DOXY 9 month/cured
4. [5] 73/F pacemaker infection ICM(NYHAIII), DM, HT none DOXY 12 month/cured
5. [6] N/A lung healthy none N/A N/A
6. [6] N/A lung healthy none N/A N/A
7. [7] N/A lung N/A N/A N/A N/A
8. [8] 35/M None (colonization) AIDS CD4 455/μL N/A N/A N/A
This case 79/F Lung, lymph nodes, multiple bones anti-IFN-γ autoantibodies none RFP, EB, CAM, and LVFX 26 month/cured
  1. N/A not available, CAPD Continuous ambulatory peritoneal dialysis, FSGS focal and segmental glomerulosclerosis, ICM Ischemic cardiomyopathy, NYHA New York Heart Association, DM diabetes mellitus, HT hypertension, AIDS Acquired immune deficiency syndrome, INH Isoniazid, RFP Rifampin, SM Streptomycin, CAM Clarithromycin, CPFX Ciprofloxin, AMK Amikacin, CFX Cefoxitin, DOXY Doxycycline, EB Ethambutol, LVFX Levofloxacin